Global Tumor Ablation Market Size, Share, Growth, Trends, and Forecast (2024 - 2031)
Global Tumor Ablation Market Scope: Historical Data (2021 – 2022), Base Year (2023), Forecast Period (2024 – 2031)
Market Segmentation: By Technology (Radiofrequency (Rf) Ablation, Microwave Ablation, Cryoablation, and Other Technologies), Mode of Treatment (Surgical Ablation, Laparoscopic Ablation, and Percutaneous Ablation), Application (Liver Cancer, Lung Cancer, Kidney Cancer, Bone Metastasis, and Other Applications), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
Market Overview
The Global Tumor Ablation Market was valued at USD 1,691.8 million in 2023 and is expected to reach USD 3,796.9 million by 2031 while growing at a CAGR of 10.6% during the forecast period (2024-2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Market Dynamics
This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global tumor ablation market growth. Ablation is a non-surgical, image-guided treatment where interventional radiologists use a needle-tipped catheter to target and shrink or destroy a tumor using extreme heat or cold. It is commonly combined with other cancer treatments like surgery, chemotherapy, or radiation therapy, tailored to the unique characteristics of the cancer and the patient's individual needs.
The continuous advancements in tumor ablation technologies, including radiofrequency ablation (RFA), microwave ablation, cryoablation, and high-intensity focused ultrasound (HIFU), along with the growth of minimally invasive procedures, are driving substantial expansion in the tumor ablation market. Despite these positive factors, obstacles such as stringent regulatory approval processes and the high costs associated with equipment and procedures may impede the market's growth.
Furthermore, the global tumor ablation industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.
Segmentation – By Technology Analysis
The Global Tumor Ablation Market is segmented among Radiofrequency (Rf) Ablation, Microwave Ablation, Cryoablation, and Other Technologies, based on technology. In 2023, Radiofrequency (Rf) Ablation accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Segmentation – By Mode of Treatment Analysis
The Global Tumor Ablation Market is segmented among Surgical Ablation, Laparoscopic Ablation, and Percutaneous Ablation, based on Mode of Treatment. In 2023, Percutaneous Ablation accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Global Tumor Ablation Market: Regional Analysis
Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Competitive Landscape
Some of the key players operating in the market are AngioDynamics Inc., Bioventus, Johnson and Johnson (NeuWave Medical, Inc.), Medtronic PLC, B. Braun Melsungen AG, Merit Medical Systems, HealthTronics, Inc., Boston Scientific Corporation, Olympus Corporation, and IceCure Medical.
Table of Contents:
1. Research Methodology and Market Scope
Research Methodology
Market Scope
2. Executive Summary
3. Global Tumor Ablation Market Dynamics
Drivers
Restraints
Opportunity
4. Global Tumor Ablation Industry Analysis
PEST Analysis
Porter's Five Force Analysis
Recent Deals Analysis
5. Global Tumor Ablation Market Segmentation, By Technology
Global Tumor Ablation Market Share Analysis, By Technology
Global Tumor Ablation Market Growth Analysis, By Technology
Global Tumor Ablation Market Trends, By Technology
o Radiofrequency (Rf) Ablation
o Microwave Ablation
o Cryoablation
o Other Technologies
6. Global Tumor Ablation Market Segmentation, By Mode of Treatment
Global Tumor Ablation Market Share Analysis, By Mode of Treatment
Global Tumor Ablation Market Growth Analysis, By Mode of Treatment
Global Tumor Ablation Market Trends, By Mode of Treatment
o Surgical Ablation
o Laparoscopic Ablation
o Percutaneous Ablation
7. Global Tumor Ablation Market Segmentation, By Application
Global Tumor Ablation Market Share Analysis, By Application
Global Tumor Ablation Market Growth Analysis, By Application
Global Tumor Ablation Market Trends, By Application
o Liver Cancer
o Lung Cancer
o Kidney Cancer
o Bone Metastasis
o Other Applications
8. Global Tumor Ablation Market Segmentation, By Region
Global Tumor Ablation Market Share Analysis, By Region
Global Tumor Ablation Market Growth Analysis, By Region
Global Tumor Ablation Market Trends, By Region
o North America
o Europe
o Asia Pacific
o Latin America
o Middle East
o Africa
9. Competitive Landscape
AngioDynamics Inc.*
o Company Overview
o Financial Performance
o Key Development/Strategies
o SWOT Analysis
Bioventus
Johnson and Johnson (NeuWave Medical, Inc.)
Medtronic PLC
B. Braun Melsungen AG
Merit Medical Systems
HealthTronics, Inc.
Boston Scientific Corporation
Olympus Corporation
IceCure Medical
*Similar analysis will be provided for each company listed above.
